2invest AG (ETR:2INV)
11.40
0.00 (0.00%)
At close: Jan 6, 2026
2invest AG Market Cap
2invest AG has a market cap or net worth of €43.64 million as of August 24, 2026. Its market cap has decreased by -38.65% in one year.
Market Cap
43.64M
Enterprise Value
35.36M
Revenue
-1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€11.40
ChartMarket Cap Chart
Since December 7, 2012, 2invest AG's market cap has increased from 35.90M to 43.64M, an increase of 21.56%. That is a compound annual growth rate of 1.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 43.64M | -30.58% |
| Dec 30, 2025 | 62.87M | -5.72% |
| Dec 30, 2024 | 66.68M | 65.71% |
| Dec 29, 2023 | 40.24M | -19.72% |
| Dec 30, 2022 | 50.12M | -32.92% |
| Dec 30, 2021 | 74.73M | -18.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 23.64M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 225.65K |